Form 4 for BDSX BIODESIX INC
Accepted 2025-04-02 00:00:00 ET · period of report 2025-04-01 · accession 0000905148-25-001049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-02 | 2025-04-01 | BDSX | Franchi Jean M. | Dir | M - OptEx | — | +26.4K | 108.1K | +32% | — |
| D | 2025-04-02 | 2025-04-01 | BDSX | Franchi Jean M. | Dir | M - OptEx | $0.00 | -26.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | M | A | 26,368 | — | 108,140 | D | — | — | (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2025-04-01 | M | D | 26,368 | $0.00 | 0 | D | — · — to — | 26,368 Common Stock | (F1) Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) These fully vested RSUs settled on April 1, 2025, and had no expiration date. |